Skip to main content
Signal8

HeartBeam, Inc. (BEAT)

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Specialties

HeartBeam, Inc. logo

HeartBeam, Inc.

NASDAQ:BEATHealthcare
+2.06%$0.5500
AH$0.5600+1.82%vs close
Mkt Cap$30.99M
Float52.59M
O/S56.35M
Vol
$ Vol
RVOL
Inst Own14.7%
SI4.7%
Earnings
Dilution
Pipeline3 lead-sponsored trials·2 active1 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
  • Not applicable
    Completed

    AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

    Vectorcardiography (VECG)

    Arrhythmias, Cardiac, Atrial Fibrillation +3

    Enrollment
    198
    Start
    Mar 2024
    Primary Completion
    Jun 2024
    Completion
    Jun 2024
    NCT06123130
  • Observational
    Recruiting

    HeartBeam ECG Registry

    Electrocardiogram (ECG)

    Atrial Fibrillation, Atrial Flutter +3

    Enrollment
    600
    Start
    Mar 2026
    Primary Completion
    Dec 2028est.
    Completion
    Dec 2028est.
    NCT07501299
  • Observational
    Active, not recruiting

    ALIGN-ACS Pilot Study

    ECG

    Acute Coronary Syndromes

    Enrollment
    120
    Start
    Mar 2026
    Primary Completion
    Jun 2026
    Completion
    Aug 2026est.
    NCT07715474